Blog

11 March 2026

New Microneedle Patch Shows Promising Tumor Clearance in Basal Cell Carcinoma Trial

New microneedle patch shows promising tumor clearance in basal cell carcinoma trial, offering a noninvasive treatment option for nodular BCC...
Read more
New Microneedle Patch Shows Promising Tumor Clearance in Basal Cell Carcinoma Trial
Delgocitinib Eases Symptoms and Improves Daily Life in Chronic Hand Eczema

Delgocitinib Eases Symptoms and Improves Daily Life in Chronic Hand Eczema

Delgocitinib offers new hope for chronic hand eczema by reducing symptoms, easing pain, and improving daily life without harsh side...
9 03 2026
Read more
How Menopause Hormones Impact Your Skin and Aesthetic Care

How Menopause Hormones Impact Your Skin and Aesthetic Care

Discover how menopause hormones affect your skin and learn expert aesthetic care tips to manage changes during perimenopause and beyond.
9 03 2026
Read more
When to Escalate Hidradenitis Suppurativa Treatment Beyond Antibiotics

When to Escalate Hidradenitis Suppurativa Treatment Beyond Antibiotics

Learn when to escalate hidradenitis suppurativa treatment beyond antibiotics to biologics for lasting relief and improved quality of life.
8 03 2026
Read more
Effective Topical JAK Inhibitors: New Hope for Chronic Hand Eczema

Effective Topical JAK Inhibitors: New Hope for Chronic Hand Eczema

Discover how effective topical JAK inhibitors offer new relief for chronic hand eczema, improving symptoms and quality of life for...
8 03 2026
Read more
Tildrakizumab Gains Popularity Among Older Patients with Plaque Psoriasis

Tildrakizumab Gains Popularity Among Older Patients with Plaque Psoriasis

Discover how tildrakizumab is gaining traction among older patients with plaque psoriasis, as new research highlights its benefits and effectiveness...
4 03 2026
Read more
FDA Grants Priority Review for Brepocitinib in Treating Dermatomyositis

FDA Grants Priority Review for Brepocitinib in Treating Dermatomyositis

FDA grants Priority Review for brepocitinib, a promising treatment for dermatomyositis. Discover the latest updates on this groundbreaking therapy and...
4 03 2026
Read more
IL-23 Inhibitor Tildrakizumab Enhances Care Continuity for Medicare Psoriasis Patients

IL-23 Inhibitor Tildrakizumab Enhances Care Continuity for Medicare Psoriasis Patients

Discover how the IL-23 inhibitor tildrakizumab improves care continuity for Medicare psoriasis patients, enhancing treatment persistence and outcomes.
3 03 2026
Read more
Difamilast Ointment: A New Non-Steroidal Treatment for Atopic Dermatitis

Difamilast Ointment: A New Non-Steroidal Treatment for Atopic Dermatitis

Discover difamilast ointment, a new non-steroidal treatment for atopic dermatitis. Learn how this PDE4 inhibitor offers relief for mild to...
26 02 2026
Read more